TheRxOS is how you fight back with data. Upload your claims. See the full picture of where you're bleeding margin — including the parts the PBMs don't want you looking at. Decide from there.
You're the owner. You're the pharmacist. You're filling, counseling, managing, and fighting PBMs — all at once. I know. I spent 24 years in this industry watching it play out from every angle.
First as a VP of Pharmacy Operations, then consulting for 40+ independent pharmacies, I've heard every version of "I don't have time for this" a thousand times — from owners, from pharmacists, from techs. Every variation of the same argument. Every excuse, every legitimate constraint, every workflow bottleneck. I sat across from the people living it every day for over two decades.
Here's what the data actually shows. When I consulted for a multi-location operator and ran this kind of revenue work by hand, it took a full-time tech — 40 hours a week — to process about 40 opportunities. One per hour.
With TheRxOS, my first client runs the same workflow with a part-time tech working 15 hours a week — submitting 100+ opportunities weekly. Almost 7× the throughput per hour. The platform does the finding, the prioritizing, and the paperwork. Your person just executes.
That 15 hours is the highest-ROI labor in your pharmacy. I'd bet on it against anything else your team does all week.
Our typical first scan surfaces $66K to $100K in monthly opportunity — that's $800K to $1.2M annualized. Your subscription is $599 a month. Even if we're wrong by 90%, the ROI still beats anything else you could spend this money on.
And here's the part nobody talks about: you see your number before you pay a dollar. Upload your claims, see what's hiding, decide from there. If the number doesn't move you, don't sign up. That's the whole pitch.
Most pharmacy owners are stacked with tools — DIR forecasting, analytics dashboards, audit protection, adherence platforms, compliance software. TheRxOS pulls those functions into one platform and gives you back the rest of the dashboard fatigue.
Most clients end up net neutral or saving money after canceling the tools we replace. The $599 pays itself back from your own subscription bill. The revenue captured is pure gain on top.
Greg* signed on during beta. He runs a single-location independent pharmacy on PioneerRx. He didn't hire anyone new. He didn't change his workflow. He pointed his part-time tech Jessica* at the opportunity list we surface every morning and let her work.
Jessica submits over 100 opportunities a week — roughly 7× what the same task used to require in full-time manual labor. Within 90 days the captured revenue had justified bringing on additional part-time hours. The program paid for more staff.
And this is at one pharmacy. Running a tool that was still half-built when they started.
Read the full case study →*Names changed at the pharmacy's request. Independent pharmacy owners who publicly optimize around PBM economics face retaliation through audits, contract non-renewals, and reimbursement adjustments. We protect every client who asks. Verifiable results and real names available under NDA on a demo call.
No new software to learn. No changes to your workflow. Here's what a normal day looks like.
Your PMS exports dispensing data automatically. The scanner reads every line, cross-references therapeutic alternatives, checks CMS formularies, flags missing therapies, and prioritizes by dollar value. No uploads. No manual work.
Talk to this patient. Fax this prescriber. Switch this NDC. She works the list top down, highest-value first. No guessing. No training manual. 15 hours a week. 100+ submissions weekly.
Every dispense gets reconciled against the opportunities your tech worked. Captured, pending, or still available — all tracked. And every conversion keeps paying every 30 days on refill.
Daily automated export from your PMS. No manual data entry. Setup in under 24 hours for supported PMS exports. Data clarity depends on what your PMS exports — we'll tell you on the demo call what to expect from your system specifically.
This isn't new business. It's money sitting in your existing patient population that your PMS doesn't surface on its own — because your PMS was built to dispense prescriptions, not find revenue gaps. Here's the part worth understanding: every player in the pharmacy chain has a reason not to show you these opportunities. Your PMS sells you software, not insight. Your wholesaler sells you drugs, not margin analysis. Your PBM benefits when you don't notice reimbursement patterns. Nobody in that chain is aligned with your profitability except you. And now, us.
Your diabetic patients filling insulin or metformin are entitled to covered supplies — test strips, pen needles, lancets, BP monitors. Most pharmacies miss this on hundreds of patients at once. When Greg saw his diabetic supply gap in isolation, he knew the platform was real. It's usually the number that convinces owners everything else is too.
Same drug class, better margin. Formulary-preferred NDCs, generic alternatives, and formulation switches that benefit the patient and improve your reimbursement in the same move. Your pharmacist reviews every recommendation before any outreach hits a prescriber. Nothing goes out without clinical sign-off.
Patients who stopped refilling. Therapies that should be combined. Audit risk flags that'll cost you in a PBM review if you don't catch them first. These require pharmacist judgment before action — but surfacing them automatically is the difference between catching a problem and getting caught.
And this is Phase 1. Once we layer in wholesaler purchasing data and PBM remittance files, you'll see things nobody in pharmacy has ever put in one place before — exactly what you paid for a drug, exactly what the PBM actually paid you for it after adjustments, and exactly where the money moved. That's coming. For now, we start with what's already plenty.
This isn't software. It's 24 years of pharmacy operations knowledge wired into a platform that gets smarter every month — because your feedback is what builds it.
First 25 pharmacies lock this rate for life. When we raise prices post-beta, you pay what you signed up for. Multi-location: $399/mo per additional location. Month-to-month. No annual contract. Cancel anytime. If you're not seeing results, you walk.
You get me — not a help desk, not a ticket system, not a junior CSM. 24 years of pharmacy operations behind every answer. Monthly founding member calls. Private Discord channel for your team.
We help you audit what you're currently paying for — DIR forecasting, analytics dashboards, compliance tools, adherence platforms — and consolidate the functions that TheRxOS already covers. Most founding clients end up net neutral or saving money on subscriptions after switching.
Four hours of monthly hands-on support for your team. Not documentation — actual implementation coaching so your tech runs the platform like Jessica does.
My independent consulting practice — normally billed separately at my full rate — is folded in for founding members. Complex opportunities, operational questions, PBM disputes, contract reviews.
Some opportunities need human judgment — audit-risk claims, complex interchanges, PBM-sensitive cases. I work directly alongside your team on the interventions that fall outside the automation.
I'd rather you walk away now than sign up and be disappointed. So here's the honest version.
Under 25K scripts/year? Reach out anyway. We're figuring out where the volume floor really is, and smaller pharmacies are often the ones getting screwed hardest.
You don't run this — your tech does. 15 hours a week, quiet corner, away from the counter. The nightly sync is automatic. You don't touch the platform day to day. You look at the revenue summary when you have a minute. That's it. I spent 24 years in pharmacy operations — first as a VP overseeing operations, then consulting for 40+ independent pharmacies. I built this specifically for that reality.
First opportunities surface within 48 hours of going live. First captured revenue typically comes within 2–3 weeks as prescriber responses come back. Greg's pharmacy hit $45K captured in 90 days starting with one part-time tech working 15 hours a week.
The platform shows them each opportunity and exactly what action is required. Sometimes that's faxing a prescriber. Sometimes it's a patient conversation. Sometimes it's switching an NDC on the next fill. They perform the action and hit submit. The platform tracks everything — what's pending, what converted, what's captured. No guesswork. No training manual to memorize.
Most common reaction we get. The fastest way to answer it is to total up just the diabetic supply gap in your patient population alone — patients already filling insulin or metformin who aren't receiving covered test strips, pen needles, or lancets. When you see that number in isolation, the rest stops looking suspicious very quickly. Every pharmacy we've onboarded asked this question. Every one of them became a client after we walked the math.
Your wholesaler sells you drugs. That's their business. When their "insights tool" points out an opportunity, it almost always steers you toward buying more of something from them. That's not analysis, that's upsell with a chart. TheRxOS doesn't sell drugs, doesn't take wholesale kickbacks, and doesn't care where you buy. We only care whether you're capturing every dollar your existing patient population entitles you to. Different job. Different incentives.
Maybe. But your opportunity set is built from your patient population, your contracts, and your patterns — not theirs. Independent pharmacies aren't really competing with each other the way most owners think. You're all losing money to the same PBMs. We'd rather help both of you catch it than play favorites.
No. Outreach is capped at 10 faxes per day per pharmacy and we never contact the same prescriber more than once per week. The asks are clinically appropriate — things prescribers expect from good pharmacies that are paying attention to their patients. Most prescribers actually appreciate the heads-up on therapy gaps they missed.
Yes. HIPAA-compliant infrastructure, encrypted in transit and at rest. We sign a Business Associate Agreement before any data transfer — non-negotiable on both sides. Your data is never shared, never sold, never used outside of finding your pharmacy's specific opportunities. If you cancel, your data is deleted within 30 days or returned to you, your choice. We're building a Public Benefit Corporation specifically so nobody can buy us and change those terms later.
$599/month. No long-term contract. Cancel anytime. Founding members lock that rate for life, even when we raise prices post-beta. Multi-location owners get $399/month on additional locations. We're confident the ROI speaks for itself — that's why we don't lock you in.
They always do. That's why we update opportunity detection continuously. The fundamentals — diabetic supplies, therapeutic alternatives, NDC optimization, adherence — have been profitable for decades. PBMs shift the specifics but the game stays the same. We adapt so you don't have to.
15 minutes. We show you the number. If it's not worth your time I'll tell you honestly and you walk away. No pitch, no follow-up, no obligation.
I'm building this solo, on a tight budget, while running the consulting practice that pays rent. I don't have VC money. I don't have a sales team. I don't have a CSM who'll answer your email while I'm in a meeting. When you sign up as a founding member you get me directly, because right now that's all I am.
That's also why the rate is $599 and why it stays $599 for you forever. Later, when I'm better capitalized, this price won't exist. Right now, we help each other — you get results, I get proof, we both get to watch independent pharmacy fight back with data.